Automated Author Profile

Xu, Siyu

Current S-Index

19.3

Sum of Dataset Indices for all datasets

Average Dataset Index per Dataset

0.7

Average Dataset Index per dataset

Total Datasets

29

Total datasets for this author

Average FAIR Score

16.8%

Average FAIR Score per dataset

Total Citations

21

Total citations to the author's datasets

Total Mentions

0

Total mentions of the author's datasets

S-Index Interpretation

S-Index Over Time

Cumulative Citations Over Time

Cumulative Mentions Over Time

Datasets

Supplementary Material for Scalable Contract Design - addCHP

Supplementary Material for Scalable Contract Design - addCHP

Authors

  • xu, siyu
0 Citations0 Mentions15% FAIR0.4 Dataset Index
10.6084/m9.figshare.29164211.v1January 2025

Supplementary Material for Scalable Contract Design - addCHP

Supplementary Material for Scalable Contract Design - addCHP

Authors

  • xu, siyu
0 Citations0 Mentions15% FAIR0.4 Dataset Index
10.6084/m9.figshare.29164211January 2025

Supplementary Material for Scalable Contract Design.xlsx

external market price coefficient and internal parameters of users.

Authors

  • xu, siyu
0 Citations0 Mentions13% FAIR0.1 Dataset Index
10.6084/m9.figshare.25651674.v1January 2024

WTAP-mediated m<sup>6</sup>A modification of TRIM22 promotes diabetic nephropathy by inducing mitochondrial dysfunction via ubiquitination of OPA1

Diabetic nephropathy (DN) is one of the most serious microvascular complications of diabetes and is the most common cause of end-stage renal disease. Tripartite motif-containing (TRIM) proteins are a large family of E3 ubiquitin ligases that contribute to protein quality control by regulating the ubiquitin – proteasome system. However, the detailed mechanisms through which various TRIM proteins regulate downstream events have not yet been fully elucidated. The current research aimed to determine the function and mechanism of TRIM22 in DN. DN models were established by inducing HK-2 cells using high glucose (HG) and diabetic mice (db/db mice). Cell viability, apoptosis, mitochondrial reactive oxygen species, and mitochondrial membrane potential were detected by Cell Counting Kit-8 and flow cytometry, respectively. Pathological changes were evaluated using hematoxylin and eosin, periodic acid schiff and Masson staining. The binding between TRIM22 and optic atrophy 1 (OPA1) was analyzed using co-immunoprecipitation. The m6A level of TRIM22 5′UTR was detected using RNA immunoprecipitation. TRIM22 was highly expressed in patients with DN. TRIM22 silencing inhibited HG-induced apoptosis and mitochondrial dysfunction in HK-2 cells. Promoting mitochondrial fusion alleviated TRIM22 overexpression-induced cell apoptosis, mitochondrial dysfunction in HK-2 cells, and kidney damage in mice. Mechanistically, TRIM22 interacted with OPA1 and induced its ubiquitination. Wilms tumor 1-associating protein (WTAP) promoted m6A modification of TRIM22 through the m6A reader insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1). TRIM22 silencing inhibited the progression of DN by interacting with OPA1 and inducing its ubiquitination. Furthermore, WTAP promoted m6A modification of TRIM22 via IGF2BP1.

Authors

  • Zhang, Zeng ;
  • Zhou, Fengzhu ;
  • Lu, Min ;
  • Zhang, Duanchun ;
  • Zhang, Xinyi ;
  • Xu, Siyu ;
  • He, Yanming
1 Citation0 Mentions13% FAIR0.5 Dataset Index
10.6084/m9.figshare.27093996January 2024

WTAP-mediated m<sup>6</sup>A modification of TRIM22 promotes diabetic nephropathy by inducing mitochondrial dysfunction via ubiquitination of OPA1

Diabetic nephropathy (DN) is one of the most serious microvascular complications of diabetes and is the most common cause of end-stage renal disease. Tripartite motif-containing (TRIM) proteins are a large family of E3 ubiquitin ligases that contribute to protein quality control by regulating the ubiquitin – proteasome system. However, the detailed mechanisms through which various TRIM proteins regulate downstream events have not yet been fully elucidated. The current research aimed to determine the function and mechanism of TRIM22 in DN. DN models were established by inducing HK-2 cells using high glucose (HG) and diabetic mice (db/db mice). Cell viability, apoptosis, mitochondrial reactive oxygen species, and mitochondrial membrane potential were detected by Cell Counting Kit-8 and flow cytometry, respectively. Pathological changes were evaluated using hematoxylin and eosin, periodic acid schiff and Masson staining. The binding between TRIM22 and optic atrophy 1 (OPA1) was analyzed using co-immunoprecipitation. The m6A level of TRIM22 5′UTR was detected using RNA immunoprecipitation. TRIM22 was highly expressed in patients with DN. TRIM22 silencing inhibited HG-induced apoptosis and mitochondrial dysfunction in HK-2 cells. Promoting mitochondrial fusion alleviated TRIM22 overexpression-induced cell apoptosis, mitochondrial dysfunction in HK-2 cells, and kidney damage in mice. Mechanistically, TRIM22 interacted with OPA1 and induced its ubiquitination. Wilms tumor 1-associating protein (WTAP) promoted m6A modification of TRIM22 through the m6A reader insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1). TRIM22 silencing inhibited the progression of DN by interacting with OPA1 and inducing its ubiquitination. Furthermore, WTAP promoted m6A modification of TRIM22 via IGF2BP1.

Authors

  • Zhang, Zeng ;
  • Zhou, Fengzhu ;
  • Lu, Min ;
  • Zhang, Duanchun ;
  • Zhang, Xinyi ;
  • Xu, Siyu ;
  • He, Yanming
1 Citation0 Mentions13% FAIR0.5 Dataset Index
10.6084/m9.figshare.27093996.v1January 2024

Supplementary Material for Scalable Contract Design.xlsx

external market price coefficient and internal parameters of users.

Authors

  • xu, siyu
0 Citations0 Mentions13% FAIR0.3 Dataset Index
10.6084/m9.figshare.25651674January 2024

CCDC 2036169: Experimental Crystal Structure Determination

No description available

Authors

  • Wang, Yu ;
  • Xu, Siyu ;
  • Li, Heng ;
  • Ma, Haixia ;
  • Zhang, Yazhou ;
  • Guo, Zhaoqi
0 Citations0 Mentions40% FAIR1.0 Dataset Index
10.5517/ccdc.csd.cc26bsw7January 2021

CCDC 2036173: Experimental Crystal Structure Determination

No description available

Authors

  • Wang, Yu ;
  • Xu, Siyu ;
  • Li, Heng ;
  • Ma, Haixia ;
  • Zhang, Yazhou ;
  • Guo, Zhaoqi
0 Citations0 Mentions40% FAIR1.0 Dataset Index
10.5517/ccdc.csd.cc26bt0dJanuary 2021

CCDC 2036174: Experimental Crystal Structure Determination

No description available

Authors

  • Wang, Yu ;
  • Xu, Siyu ;
  • Li, Heng ;
  • Ma, Haixia ;
  • Zhang, Yazhou ;
  • Guo, Zhaoqi
0 Citations0 Mentions15% FAIR0.4 Dataset Index
10.5517/ccdc.csd.cc26bt1fJanuary 2021

CCDC 2036170: Experimental Crystal Structure Determination

An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.

Authors

  • Wang, Yu ;
  • Xu, Siyu ;
  • Li, Heng ;
  • Ma, Haixia ;
  • Zhang, Yazhou ;
  • Guo, Zhaoqi
0 Citations0 Mentions13% FAIR0.3 Dataset Index
10.5517/ccdc.csd.cc26bsx8January 2021